Free Trial
LON:JAGI

JPMorgan Asia Growth & Income 12/13/2024 Earnings Report

JPMorgan Asia Growth & Income logo
GBX 589.56 +5.56 (+0.95%)
As of 11:43 AM Eastern

JPMorgan Asia Growth & Income EPS Results

Actual EPS
GBX 4.51
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

JPMorgan Asia Growth & Income Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

JPMorgan Asia Growth & Income Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

JPMorgan Asia Growth & Income Earnings Headlines

Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
JPMorgan trust examined for higher yield potential
JPMorgan Trusts report updated gearing ratios
See More JPMorgan Asia Growth & Income Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like JPMorgan Asia Growth & Income? Sign up for Earnings360's daily newsletter to receive timely earnings updates on JPMorgan Asia Growth & Income and other key companies, straight to your email.

About JPMorgan Asia Growth & Income

Your performance potential - our Asia insight Transform Asian opportunity into your growth and income potential Asia is transforming rapidly—from urbanisation and digitalisation to the rise of AI and a growing middle class. JPMorgan Asia Growth & Income is designed to capture this investment potential, aiming to deliver both long-term growth and regular income. Every year, the Trust targets a 6% payout of portfolio value1 as quarterly dividends, offering UK investors a way to diversify and strengthen their income strategy while accessing one of the world’s most dynamic regions. The local and global expertise to find Asia’s future leaders Asia-Pacific is a diverse region with many markets and opportunities. Identifying the best ideas requires significant resources and insight. J.P. Morgan Asset Management is a leading specialist in Asia-Pacific equities. The Trust’s co-managers are based in Hong Kong and Singapore, supported by 100 analysts, traders, and sector specialists in nine locations. With a global research framework, the team continually tracks and evaluates thousands of Asian companies, assessing each opportunity in an international context to find future world leaders. Your all-weather portfolio of best ideas in Asia JPMorgan Asia Growth & Income is built to navigate all market conditions, making it an ideal core holding for both new and experienced Asia investors. The Trust uses a disciplined, risk-aware approach and is free to select its highest-conviction ideas across any market or sector. With a concentrated portfolio of 50–80 stocks, opportunities are never diluted. From tech to energy, retailers to financials, the Trust brings together companies benefiting from Asia’s transformation. It has outperformed its benchmark, the MSCI AC Asia Ex Japan Index, in seven out of ten years2, net of fees, making it a compelling choice for growth and income. 1 Calculated as 1.5% of net asset value at the start of each quarter 2 JPMorgan Asia Growth & Income (LON:JAGI), Annual Report, as at 30 September 2024

View JPMorgan Asia Growth & Income Profile